Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (#2016/05865-8, #2016/04595-7)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (PROEX)
Received: 6 June 2019
Accepted: 23 June 2020
First Online: 20 July 2020
Ethics approval and consent to participate
: This study was approved by the local Medical Ethics Committee of Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), and all participants and parents/legal guardians gave their written informed consent after having been enlightened the details of the procedure.
: Not applicable.
: Dr. Polanczyk has served as a speaker and/or consultant to Shire, Teva, and Johnson & Johnson; has developed educational material for Janssen-Cilag and Shire. All the remaining authors report no biomedical financial interests or potential conflicts of interest.